Santen Pharmaceutical Co Stock Widgets and Gadgets
SNPHY Stock | USD 9.75 0.07 0.72% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- SNPHY Santen Pharmaceutical Co
- SNPHY 9.75 0.07
- Low 9.75
- High 9.75
- Alpha 0.15
- Beta -0.89
- Return On Equity -0.0264
- Return On Asset -0.001
- Profit Margin (0.03) %
- Operating Margin (0) %
- Current Valuation 2.6 B
- Shares Outstanding 388.22 M
- Shares Owned By Institutions 0.02 %
- Price To Earning 14.22 X
- Price To Book 1.39 X
- Price To Sales 0.01 X
- Revenue 266.26 B
- Gross Profit 156.59 B
- EBITDA 53.91 B
- Net Income 27.22 B
- Cash And Equivalents 69.53 B
- Cash Per Share 176.84 X
- Total Debt 32.93 B
- Debt To Equity 0.1 %
- Current Ratio 2.48 X
- Book Value Per Share 780.63 X
- Cash Flow From Operations 46.04 B
- Earnings Per Share 0.47 X
- Number Of Employees 4.32 K
- Beta 0.38
- Market Capitalization 2.94 B
- Total Asset 459.98 B
- Retained Earnings 230.22 B
- Working Capital 106.3 B
- Current Asset 156.63 B
- Current Liabilities 50.32 B
- Annual Yield 0.03 %
- Five Year Return 1.68 %
- Net Asset 459.98 B
- Last Dividend Paid 16.0
- Daily Balance Of Power 9.2 T
- Rate Of Daily Change 1.01
- Day Median Price 9.75
- Day Typical Price 9.75
- Price Action Indicator 0.035
- Period Momentum Indicator 0.07
- Relative Strength Index 64.5
Market Snapshot Widget Example
DAX Index Germany | 18,477 0.50 | |
Taiwan Weighted Taiwan | 20,200 0.37 | |
PSI 20 Stock Portugal | 6,277 0.88 | |
CROBEX Croatia | 2,842 0.22 | |
Budapest SE Hungary | 64,830 0.27 | |
IDX 30 Jakarta Indonesia | 503.32 0.82 | |
ISEQ 20 Price Ireland | 1,642 0.89 | |
NYSE Comp USA | 18,255 1.09 | |
Tel Aviv 35 Israel | 2,005 0.34 | |
Coreshares Index Tracker South Afric | 1,046 0.38 | |
IPC MEXICO Mexico | 57,369 0.17 | |
KL Technology Malaysia | 64.31 0.42 | |
IBEX 35 Index Spain | 11,111 1.09 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,523 0.70 | |
SPASX Dividend Opportunities Australia | 1,668 0.31 | |
HNX 30 Vietnam | 532.84 0.75 | |
Bucharest BET-NG Romania | 1,206 0.37 | |
AMS Small Cap Netherlands | 1,217 0.32 | |
Oslo Exchange Mutual Norway | 1,280 0.47 | |
BEL Small Belgium | 9,225 0.4 | |
RTSI Index Russia | 1,128 1.15 | |
Basic Materials Brazil | 6,005 1.59 | |
Swiss Leader Price Switzerland | 1,919 0.23 | |
Athens General Comp Greece | 1,418 0.35 | |
Stock Exchange Of Thailand | 1,381 0.26 | |
PX Prague Stock Czech Repub | 1,490 0.07 | |
THE PHILIPPINE STOCK Philippines | 6,904 0.08 | |
WIG 30 Poland | 2,975 0.34 | |
BIST Electricity Turkey | 536.44 0.81 |
Investing Ideas
In addition to having Santen Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Santen Pharmaceutical
Compare Santen Pharmaceutical To Peers
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Santen Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Santen Pharmaceutical information on this page should be used as a complementary analysis to other Santen Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Santen Pink Sheet analysis
When running Santen Pharmaceutical's price analysis, check to measure Santen Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santen Pharmaceutical is operating at the current time. Most of Santen Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Santen Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santen Pharmaceutical's price. Additionally, you may evaluate how the addition of Santen Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
CEOs Directory Screen CEOs from public companies around the world | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |